NCT06980493View on ClinicalTrials.gov

Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution Working

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

June 1, 2025

Study Completion Date

August 1, 2025

Conditions

Tinea Capitis

Interventions

DRUG

Amphotericine in liposome (Ambisome®)

The aim of the study will be to evaluate the efficacy and safety of topical amphotericin B solution in treatment of non-inflammatory type of tinea capitis after resistant response to oral systemic treatment

Trial Locations (1)

Unknown

Sohag faculty of medicine, Sohag

All Listed Sponsors

lead

Sohag University

OTHER